Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trialIan Judson, Winette T.A. van der Graaf, J. Martijn Kerst et al.|The Lancet Oncology|2014Cited by 1.2k
Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomasStefan Sleijfer, Jean‐Yves Blay, M. Ouali et al.|European Journal of Cancer|2009Cited by 246
LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcomaMorten Nielsen, Inge Marie Svane, Tine Monberg et al.|OncoImmunology|2023Cited by 40